Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Atherosclerosis|April 23, 2026
Cost-effectiveness of alternative cascade screening strategies for familial hypercholesterolemia with realistic cascade screening acceptance rates and use of novel treatmentJing Lou, Kok Joon Chong, Sharon Li Ting Pek, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2013
Small molecule inhibitors of trans-translation have broad-spectrum antibiotic activityNitya S Ramadoss, John N Alumasa, Lin Cheng, et al.
Acta Diabetologica|March 21, 2023
Associations of non-invasive indices of liver steatosis and fibrosis with progressive kidney impairment in adults with type 2 diabetesMei Chung Moh, Sharon Li Ting Pek, Kenny Ching Pan Sze, et al.
Diabetes/Metabolism Research and Reviews|June 9, 2018
Association of circulating proinflammatory marker, leucine-rich-α2-glycoprotein (LRG1), following metabolic/bariatric surgerySharon Li Ting Pek, Anton Kui Sing Cheng, Michelle Xueqin Lin, et al.
Diabetes Research and Clinical Practice|February 8, 2020
Plasma osteoprotegerin as a biomarker of poor glycaemic control that predicts progression of albuminuria in type 2 diabetes mellitus: A 3-year longitudinal cohort studyAngela Mei Chung Moh, Sharon Li Ting Pek, Jianjun Liu, et al.
Diabetes|September 5, 2020
A Multifunctional Role of Leucine-Rich α-2-Glycoprotein 1 in Cutaneous Wound Healing Under Normal and Diabetic ConditionsChenghao Liu, Melissa Hui Yen Teo, Sharon Li Ting Pek, et al.
Atherosclerosis|January 22, 2018
Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center studySharon Li Ting Pek, Sanjaya Dissanayake, Jessie Choi Wan Fong, et al.
The Journal of Clinical Endocrinology and Metabolism|April 23, 2021
Association of Genetic Variants for Plasma LRG1 With Rapid Decline in Kidney Function in Patients With Type 2 DiabetesResham Lal Gurung, Rajkumar Dorajoo, Yiamunaa M, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 2010
Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodiesSeth A Ettenberg, Olga Charlat, Michael P Daley, et al.
Cancer Research|August 10, 2013
An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulinAndrew P Garner, Carl U Bialucha, Elizabeth R Sprague, et al.
Pageof 5